Shandong Oriental Ocean Sci-tech Co., Ltd.
东方海洋
002086
Shenzhen Stock Exchange
Company Profile
The company is a national-level aquatic fine breed farm, boasting comprehensive core competitive advantages in resources, technology, scientific research, talent, scale, quality control, and brand. Based on its existing competitive advantages and relying on various national preferential and supportive policies, the Marine Business Division highlights the advantages of large-scale, standardized, and high-precision development in processing operations, while the breeding business emphasizes the characteristics of pollution-free, high-quality, and highly safe. The Big Health Business Division continuously enhances its scientific research capabilities, accelerates the improvement of industrial layout, and builds market sales channels.Rooted in these two industries, the company seizes both domestic and international markets, enhances brand awareness and its core competitiveness, and strives to achieve sustainable development driven by dual engines (the two business divisions) and technological innovation. Currently, the company has 7 national R&D platforms, 11 provincial R&D platforms, and 6 industry-university-research cooperation platforms. Relying on these technological R&D platforms, the company has gradually built a technological innovation system that integrates key technological project research, breakthroughs in core technologies, development of original applied technologies, and transformation of research achievements.
Full description
Shandong Oriental Ocean Sci-Tech Co., Ltd. (hereinafter referred to as "the company") mainly engaged in sea water breeding, breeding, aquatic products processing, biotechnology,Bonded warehousing logistics and in vitro diagnostic reagents’ R & D, production, sales and testing services,it is a national high-tech enterprises and national enterprise technology center, national key leading enterprises in agricultural industrialization, national aquatic seed farm,which integrates mariculture,refrigerated processing,biological products, pharmaceutical intermediates, scientific research and promotion and international trade. The company's mariculture business mainly includes breeding, processing and marketing of rare fish such as sea cucumber, among which sea cucumber is the main product of the company.Aquatic products processing business mainly includes fish processing, sales and other aquatic products, the main product is a variety of frozen fish fillets.The business of in vitro diagnosis mainly includes the research and development, production，sale of in vitro diagnostic reagents and testing services. In 2017, the company makes every effort to promote the joint development of the health industry and the marine industry, accelerates the transformation and upgrading of the company industry, and realizes both of the two industries’ innovative sustainable development.